Dr. Jeffrey R. Jay, M.D. »

Sol Gel Technologies shares owned by Dr. Jeffrey R. Jay, M.D.

Quarter-by-quarter ownership of Sol Gel Technologies (SLGL) shares owned by Dr. Jeffrey R. Jay, M.D. from 13F filings

Historical chart of Dr. Jeffrey R. Jay, M.D. investment in Sol Gel Technologies

Tip: Access up to 7 years of quarterly data

All positions including Sol Gel Technologies held by Dr. Jeffrey R. Jay, M.D. consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sol Gel Technologies by Dr. Jeffrey R. Jay, M.D.

Quarter filed Position value Share count Share price at filing
2026-03-31 $22M 274k 79.22

More positions owned by Dr. Jeffrey R. Jay, M.D.

Apogee Therapeutics (APGE)
Vor Biopharma Com New (VOR)
Zura Bio Class A Ord Shs (ZURA)
Amylyx Pharmaceuticals (AMLX)
Immunitybio Put Option (IBRX)
Nektar Therapeutics Com New (NKTR)
Sol-gel Technologies Shs New (SLGL)
Alumis (ALMS)
Bright Minds Biosciences Com New (DRUG)
Annexon (ANNX)
Kalvista Pharmaceuticals (KALV)
Immunovant (IMVT)
Jade Biosciences Com New (JBIO)
Contineum Therapeutics Cl A (CTNM)
Zenas Biopharma (ZBIO)

View all positions for Dr. Jeffrey R. Jay, M.D.

Top funds holding Sol Gel Technologies

Opaleye Management
Dr. Jeffrey R. Jay, M.D.
Phoenix Holdings
Trails Edge Capital Partners
Citadel Advisors
Squadron Capital Management
Yelin Lapidot Holdings Management
Jane Street
Raymond James Financial
Morgan Stanley
LPL Financial
Hrt Financial
BlackRock
UBS Group
Royal Bank of Canada

View all funds holding Sol Gel Technologies